The impact of Cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice-Reference-Cited by-同舟云学术

The impact of Cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice

Published:2006 Issue:2 Volume:15 Page:107-114
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidem. Drug Safe.

Author:

Mulder Hans,Herder Anita,Wilmink Frederik W.,Tamminga Wim J.,Belitser Svetlana V.,Egberts Antoine C. G.

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference27 articles.

1. The impact of the polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment

2. Pharmacogenetic Methods as a Complement to Therapeutic Monitoring of Antidepressants and Neuroleptics

3. Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype

4. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

5. Therapeutic Drug Monitoring of Tricyclic Antidepressants: How Does it Work under Clinical Conditions?

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FLUVOXAMINE;Prescriber's Guide – Children and Adolescents;2024-05-02

2. An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care;The Pharmacogenomics Journal;2019-01-16

3. Executive Summary: American Association of Clinical Chemistry Laboratory Medicine Practice Guideline—Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients;The Journal of Applied Laboratory Medicine;2018-01-01

4. Availability of CYP2D6 genotyping results in general practitioner and community pharmacy medical records;Pharmacogenomics;2017-06

5. Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs;The Pharmacogenomics Journal;2016-07-19